NDIC High-Tech to reduce stake in Zhejiang Medicine

National Development and Investment Corporation High-Tech Investment Co., Ltd. ("NDIC High-Tech"), a shareholder holding over 5% of Zhejiang Medicine Co., Ltd., has announced its intention to reduce its holding. NDIC High-Tech currently holds 150,127,573 shares, representing 15.61% of the company's total share capital. The proposed reduction will be conducted via centralized bidding.

NDIC High-Tech plans to divest up to 9,616,377 shares, equivalent to no more than 1% of Zhejiang Medicine's total share capital. The divestment period is scheduled to run for three months, commencing 15 trading days after October 23, 2025, and concluding by January 22, 2026. This move is driven by the shareholder's operational development needs.

The shares targeted for reduction include those acquired prior to Zhejiang Medicine's IPO and shares obtained through stock dividends. The company has clarified that this reduction plan will not impact its governance structure or continuous operations, and there is no expectation that it will lead to a change in the company's control.